Intrinsiqq
Zyversa Therapeutics Inc. logo

Zyversa Therapeutics Inc.

ZVSA

Compare
⚠ Showing the latest available close (Nov 13, 2026, 9 days ago). Our price provider hasn't published a newer EOD for this ticker yet. Price-dependent metrics (P/E, P/FCF, yield) may not reflect current market conditions.

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$809.59
EPS-$3.32
P/E-0.00
P/FCF–
EV/EBITDA0.01
FCF Yield–
Div. Yield–
Net Debt/FCF–
Zyversa Therapeutics Inc. intrinsic value

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$24M

▼ -165.1% YoY

Op. Margin

–

ROIC

-1277.14%

▼ -399.3pp YoY

Cash Flow & Balance Sheet

FCF

N/A

Op. Cash Flow (TTM)

-$4M

▲ +32.0% YoY

Net Debt

-$303K

Net Cash Position

Cash & Equiv.

$303K

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with ZVSA

CompareIntrinsic value
ANABAnaptysBio Inc.
$46.63-1.62%20
KZRKezar Life Sciences, Inc.
No recent price20
SCNXScienture Holdings Inc.
$2.28-6.45%0
UNCYUnicycive Therapeutics Inc.
$3.35-5.10%10
XOMAXOMA Corporation
€0.04-3.86%64
FBIOFortress Biotech Inc.
$1.90+7.34%59
ANIPAni Pharmaceuticals Inc.
$68.55-0.84%85
GTBPGT Biopharma, Inc.
$2.96-6.92%20

Zyversa Therapeutics (ZVSA) in two numbers

Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-0.00
Negative: a loss over the last twelve months.
Financials

Questions about Zyversa Therapeutics

Does Zyversa Therapeutics (ZVSA) pay a dividend?

No. Zyversa Therapeutics (ZVSA) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 11 May 2026 (period ending 31 Mar 2026), SEC. Price: last close 13 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in ZVSA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ZVSA

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.